Parmax Pharma Ltd | Scrip Code : 540359 | Quarter ending :June 2018 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 3 | 11,52,450 | 11,52,450 | 30.80 | 11,52,450 | 30.80 | 7,48,260 | 64.93 | 11,51,750 | - | - | - | (B) Public | 795 | 25,88,850 | 25,88,850 | 69.20 | 25,88,850 | 69.20 | | 0.00 | 11,57,810 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 798 | 37,41,300 | 37,41,300 | 100.00 | 37,41,300 | 100.00 | 7,48,260 | 20.00 | 23,09,560 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|